Pressemitteilung BoxID: 758689 (BIOTRONIK)
  • Woermannkehre 1
  • 12359 Berlin
  • Ansprechpartner
  • Manuela Schildwächter
  • +49 (30) 689051414

World's First and Only ICD Offering 3 Tesla MRI Access Launched in Japan

BIOTRONIK Increases ProMRI Device Portfolio in Japan with Launch of Iperia 7 VR-T and DR-T DF4 ICDs

(PresseBox) (TOKYO, Japan, ) BIOTRONIK, the world’s leading manufacturer of MR conditional cardiac devices, has announced the Japanese market release of its Iperia 7 VR-T and DR-T DF4 implantable cardiac defibrillators (ICDs). Iperia is the only ICD worldwide approved for 3.0 tesla (T) magnetic resonance imaging (MRI) with an exclusion zone and 1.5 T full-body scanning.

Dr. Masatsugu Ohe, from Kurume University Hospital in Japan welcomed the news and said the devices deliver more options to physicians and patients. “The new Iperia 7 ProMRI series is a very versatile ICD system now compatible for both 1.5 T and 3.0 T MRI scans made possible without compromising any existing device functions. This enhanced lineup of ICDs brings an improved diagnostic ability which is a true benefit for both the patients and the medical professionals treating them.” 

With Iperia, a new option for discrimination of supraventricular tachycardia has been added with the MorphMatch morphology detection algorithm. The devices also feature BIOTRONIK Home Monitoring®, which allows physicians to remotely follow their patients’ device status on a daily basis. This has been shown to reduce inappropriate therapies by 52 percent1, as proven in the ECOST trial.

Jeffrey Annis, Managing Director BIOTRONIK Japan said the company’s commitment to ProMRI technology particularly compliments the Japanese market. “Japanese medical professionals have long realized that MRI is the optimal diagnostic procedure for a variety of conditions. There is a higher prevalence of MRI machines per million people in Japan than anywhere else in the world and 3.0 T MRI machines are becoming the preferred choice,” he commented. “BIOTRONIK recognizes that cardiac device patients deserve access to this vital diagnostic tool. We have therefore developed the world’s largest portfolio of ProMRI devices, which are now being embraced by Japanese patients and physicians.”

For more information, visit:


1Guedon-Moreau L et al. Eur Heart J. 2013, 34(8).

Website Promotion


One of the world's leading manufacturers of cardio and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; and the world's first implantable cardioverter defibrillators devices with 3.0T ProMRI® technology.

Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an